NSE: WOCKPHARMA | BSE: 532300

Momentum Trap

Download real time

1465.30 118.50 (8.80%)

198.95% Gain from 52W Low

2.3M NSE+BSE Volume

High volume+gain today

NSE 30 May, 2025 3:31 PM (IST)

23,809

Market Cap

High in industry

1.5

Beta 1Year

Very High Volatility

Rapid Results

Q4FY25 & FY25 Result Announced for Wockhardt Ltd. See details

Wockhardt Ltd. News and Updates

Keep track of all breaking news on Wockhardt Ltd. from all sources in a single place.

Load latest

16 Sep 2024

1465.30

8.80%

Wockhardt clinches BIRAC innovator award for novel antibiotic

Business Line

The drug addresses a significant medical need, as existing treatments like Azithromycin face resistance issues or lack comprehensive coverage of respiratory pathogens

Wockhardt Ltd. has gained 10.99% in the last 1 Week

07 Sep 2024

1465.30

8.80%

Wockhardt denies Carol Info rent payment allegations, link with Sebi orders

Business Standard

Drug firm Wockhardt has denied allegations regarding payment of rent by Carol Info Services and its connection with certain orders passed by SEBI in relation to the company. "In this regard, we categorically deny these allegations and state that these allegations are completely baseless and misleading," Wockhardt said in a regulatory filing late Friday. It said the company has acted and continues to act in compliance with all applicable laws. On Friday, the Congress' media and publicity department head, Pawan Khera said that between 2018 and 2024, Madhabi Buch - as a whole-time member and later chairperson of Securities and Exchange Board of India (SEBI) - had been receiving rental income amounting to Rs 2.16 crore from Carol Info Services, a company affiliated to Wockhardt. Mumbai-based Wockhardt was being investigated by SEBI for various cases, including that of insider trading during 2023, he said at a press conference at the AICC headquarters in Delhi.

Wockhardt Ltd. has gained 25.41% in the last 3 Months

02 Jul 2024

1465.30

8.80%

Wockhardt enters last mile to bring two of its promising antibiotics to India

Business Line

Out-licencing talks for overseas markets, after global approvals, says Chairman

Wockhardt Ltd. has gained 10.99% in the last 1 Week

01 Jul 2024

1465.30

8.80%

Wockhardt stock soars over 19% after its investigational antibiotic Zaynich successfully treats cancer patient in US

Business Line

This marked the first instance in US, where Zaynich had been used to combat a complex infection caused by extreme-drug-resistant pseudomonas

Wockhardt Ltd. is trading above all available SMAs

28 Jun 2024

1465.30

8.80%

Wockhardt's novel antibiotic Zaynich to be launched in India by end of FY25

Business Standard

Global launch in FY26 after multinational clinical trial ends

Wockhardt Ltd. has gained 160.38% in the last 1 Year

Wockhardt's investigational antibiotic shows significant effectiveness in global Phase 3 trials

Business Today | 28 Jun 2024

28 Jun 2024

1465.30

8.80%

Wockhardt Launches New Antibiotic With $25-Billion Market Potential

NDTV Profit

The company has invested over $500 million on its research efforts till now.

Wockhardt Ltd.'s price crossed above 100Day SMA today

29 May 2024, 04:43PM

1465.30

8.80%

to see Rapid results content

29 May 2024, 12:32PM

1465.30

8.80%

Wockhardt posts net loss of 177 crore in Q4; antibiotic products make progress

Business Line

Wockhardt's total income for the last quarter under review was 754 crore, from 710 crore in the same period last year

Wockhardt Ltd. has gained 10.99% in the last 1 Week

Wockhardt Q4 Result: Loss At Rs 177 Crore

NDTV Profit | 28 May 2024, 08:53PM

30 Mar 2024, 09:27AM

1465.30

8.80%

Wockhardt To Use Funds Raised Via QIPs To Retire External Debt: Founder Habil Khorakiwala

NDTV Profit

Wockhardt raised Rs 480 crore by issuing shares via the qualified institutional placement route.

Wockhardt Ltd.'s price crossed above 100Day SMA today

27 Mar 2024

1465.30

8.80%

Wockhardt Shares Locked In 5% Upper Circuit After Raising Rs 480 Crore Via QIP

NDTV Profit

Post QIP, Wockhardt's paid-up equity share capital increased to Rs 76.71 crore, consisting of 15.34 equity shares with a face value of Rs 5 each.

Wockhardt Ltd. has gained 10.99% in the last 1 Week

Wockhardt stock locked in 5% upper circuit after Prashant Jain, Madhusudan Kela and others invest in QIP

Moneycontrol | 27 Mar 2024

Is Wockhardt Ltd. worth buying?

443 Votes:

Buy 73.14%

Sell 17.38%

Hold 9.48%